MedTrace Logo

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

NCT03193151 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-11-17

No results posted yet for this study

Summary

INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.

Conditions

  • Liver Dysfunction

Interventions

PROCEDURE

liver biopsy

5 mm fragment of liver transplant biopsy taken for clinical indication

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Philip F Halloran, MD, PhD · University of Alberta

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-19
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • United States
  • Australia
  • Canada
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03193151 on ClinicalTrials.gov